Literature DB >> 13130011

Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov.

Debby V Cousins1, Ricardo Bastida2, Angel Cataldi3, Viviana Quse4, Sharon Redrobe5, Sue Dow5, Padraig Duignan6, Alan Murray6, Christine Dupont6, Niyaz Ahmed7, Des M Collins8, W Ray Butler9, David Dawson10, Diego Rodríguez2, Julio Loureiro3, Maria Isabel Romano3, A Alito3, M Zumarraga3, Amelia Bernardelli11.   

Abstract

A comparison of Mycobacterium tuberculosis complex isolates from seals (pinnipeds) in Australia, Argentina, Uruguay, Great Britain and New Zealand was undertaken to determine their relationships to each other and their taxonomic position within the complex. Isolates from 30 cases of tuberculosis in six species of pinniped and seven related isolates were compared to representative and standard strains of the M. tuberculosis complex. The seal isolates could be distinguished from other members of the M. tuberculosis complex, including the recently defined 'Mycobacterium canettii' and 'Mycobacterium caprae', on the basis of host preference and phenotypic and genetic tests. Pinnipeds appear to be the natural host for this 'seal bacillus', although the organism is also pathogenic in guinea pigs, rabbits, humans, Brazilian tapir (Tapirus terrestris) and, possibly, cattle. Infection caused by the seal bacillus is predominantly associated with granulomatous lesions in the peripheral lymph nodes, lungs, pleura, spleen and peritoneum. Cases of disseminated disease have been found. As with other members of the M. tuberculosis complex, aerosols are the most likely route of transmission. The name Mycobacterium pinnipedii sp. nov. is proposed for this novel member of the M. tuberculosis complex (the type strain is 6482(T)=ATCC BAA-688(T)=NCTC 13288(T)).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130011     DOI: 10.1099/ijs.0.02401-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  70 in total

1.  Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy.

Authors:  Hajime Kanamori; Katsuhiko Isogami; Takashi Hatakeyama; Hiroo Saito; Kazuyoshi Shimada; Bine Uchiyama; Noboru Aso; Mitsuo Kaku
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Revisiting the evolution of Mycobacterium bovis.

Authors:  Serge Mostowy; Jackie Inwald; Steve Gordon; Carlos Martin; Rob Warren; Kristin Kremer; Debby Cousins; Marcel A Behr
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

3.  Comparison of GenoType MTBC with RFLP-PCR and multiplex PCR to identify Mycobacterium tuberculosis complex species.

Authors:  M P Romero Gómez; L Herrera-León; M S Jiménez; J García Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

4.  An improved fluorescent amplified fragment length polymorphism method for typing Mycobacterium tuberculosis.

Authors:  Yankuba Kassama; Michael Shemko; Nandini Shetty; Zack Fang; Graham Macintire; Vanya Gant; Ali Zumla; Royston Goodacre
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates.

Authors:  I K Neonakis; Z Gitti; E Petinaki; S Maraki; D A Spandidos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

6.  "Mycobacterium canettii" isolated from a human immunodeficiency virus-positive patient: first case recognized in the United States.

Authors:  Akos Somoskovi; Jillian Dormandy; Andrew R Mayrer; Martin Carter; Nancy Hooper; Max Salfinger
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

7.  Characterization of Mycobacterium caprae isolates from Europe by mycobacterial interspersed repetitive unit genotyping.

Authors:  Wolfgang M Prodinger; Anita Brandstätter; Ludmila Naumann; Maria Pacciarini; Tanja Kubica; Maria Laura Boschiroli; Alicia Aranaz; György Nagy; Zeljko Cvetnic; Matjaz Ocepek; Artem Skrypnyk; Wilfried Erler; Stefan Niemann; Ivo Pavlik; Irmgard Moser
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 8.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

9.  Immune responses in cattle inoculated with Mycobacterium bovis, Mycobacterium tuberculosis, or Mycobacterium kansasii.

Authors:  W R Waters; A O Whelan; K P Lyashchenko; R Greenwald; M V Palmer; B N Harris; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

10.  Signal regulatory protein alpha (SIRPalpha) cells in the adaptive response to ESAT-6/CFP-10 protein of tuberculous mycobacteria.

Authors:  W Ray Waters; Mitchell V Palmer; Brian J Nonnecke; Tyler C Thacker; D Mark Estes; Michelle H Larsen; William R Jacobs; Peter Andersen; James McNair; F C Minion; Konstantin P Lyashchenko; R Glyn Hewinson; H Martin Vordermeier; Randy E Sacco
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.